Aethlon Medical (AEMD)
(Delayed Data from NSDQ)
$0.36 USD
-0.03 (-8.21%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.35 -0.01 (-2.23%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Aethlon Medical, Inc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 0 | 1 | 0 | 1 | 1 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 1 | 0 | 1 | 1 |
Selling & Adminstrative & Depr. & Amort Expenses | 13 | 12 | 11 | 9 | 7 |
Income After Depreciation & Amortization | -13 | -12 | -10 | -8 | -6 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -12 | -12 | -10 | -8 | -6 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -12 | -12 | -10 | -8 | -6 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -12 | -12 | -10 | -8 | -6 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -12 | -12 | -10 | -8 | -6 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -13 | -12 | -10 | -8 | -6 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 2.51 | 2.05 | 1.48 | 1.21 | 0.34 |
Diluted EPS Before Non-Recurring Items | -4.86 | -5.90 | -7.10 | -6.50 | -18.70 |
Diluted Net EPS (GAAP) | -4.86 | -5.90 | -7.10 | -6.50 | -18.70 |
Fiscal Year end for Aethlon Medical, Inc falls in the month of March .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 2.62 | 2.49 | 3.57 | 3.18 | 3.41 |
Income After SG&A, R&D, and Dept/Amort Expenses | -2.62 | -2.49 | -3.57 | -3.18 | -3.41 |
Non-Operating Income | 0.05 | 0.06 | 0.10 | 0.14 | 0.13 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -2.57 | -2.43 | -3.47 | -3.03 | -3.28 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -2.57 | -2.43 | -3.47 | -3.03 | -3.28 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -2.57 | -2.43 | -3.47 | -3.03 | -3.28 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 7.46 | 2.67 | 2.52 | 2.48 | 2.43 |
Diluted EPS Before Non-Recurring Items | -0.34 | -0.91 | -1.37 | -1.22 | -1.30 |
Diluted Net EPS (GAAP) | -0.34 | -0.87 | -1.37 | -1.22 | -1.40 |